Table 1.
Mean (SD) or % | Treatment Time <210 min | Kt/V <1.2 | Ultrafiltration Volume >5.7% | KD <3 mEq/L | ||||
---|---|---|---|---|---|---|---|---|
No | Yes | No | Yes | No | Yes | No | Yes | |
Patients (n) | 28,878 | 8536 | 18,824 | 7273 | 26,880 | 3970 | 6606 | 29,629 |
Age (yr) | 61.0 (14.6) | 64.6 (15.3)a | 62.0 (14.8) | 61.2 (14.5)b | 62.5 (14.6) | 57.2 (14.9)a | 64.4 (14.5) | 61.3 (14.8)a |
Male | 60 | 49a | 53 | 72a | 58 | 55a | 54 | 59a |
Black | 13 | 15a | 14 | 13a | 13 | 13a | 13 | 14a |
Vintage | 4.2 (5.5) | 2.0 (3.8)a | 4.9 (5.7) | 2.6 (4.3)a | 3.7 (5.2) | 6.3 (6.2)a | 1.8 (3.5) | 4.1 (5.5)a |
Body mass index | 24.9 (5.8) | 24.1 (5.2)a | 24.2 (5.6) | 25.4 (5.9)a | 25.0 (5.7) | 21.5 (4.0)a | 25.8 (5.9) | 24.5 (5.6)c |
Catheter | 23 | 35a | 18 | 28a | 23 | 11a | 41 | 22a |
Comorbid conditions | ||||||||
coronary artery disease | 45 | 46 | 46 | 42 | 46 | 40 | 54 | 43a |
other cardiovascular | 35 | 32c | 36 | 31a | 34 | 35a | 39 | 33a |
cerebrovascular disease | 16 | 18a | 17 | 16 | 17 | 14a | 20 | 16a |
congestive heart failure | 35 | 37 | 35 | 33 | 34 | 33a | 42 | 34a |
diabetes | 38 | 40 | 35 | 44a | 38 | 35b | 46 | 37a |
Laboratory results | ||||||||
hemoglobin (g/dl) | 10.9 (1.7) | 10.5 (1.7)a | 11.1 (1.6) | 10.5 (1.8)a | 10.9 (1.7) | 10.6 (1.6) | 10.8 (1.7) | 10.8 (1.7)a |
albumin (g/dl) | 3.7 (0.5) | 3.6 (0.6)a | 3.7 (0.5) | 3.7 (0.6)a | 3.7 (0.5) | 3.8 (0.5)a | 3.5 (0.6) | 3.7 (0.5)a |
potassium (mEq/L) | 5.0 (0.8) | 4.8 (0.8)a | 5.0 (0.8) | 4.9 (0.8)a | 4.9 (0.8) | 5.2 (0.8)a | 4.7 (0.8) | 5.0 (0.8)a |
phosphorous (mg/dl) | 5.6 (1.8) | 5.6 (1.9)a | 5.5 (1.7) | 5.7 (1.9)a | 5.5 (1.8) | 5.9 (1.9)a | 5.4 (1.9) | 5.6 (1.8)a |
parathyroid hormone (pg/ml) | 177 (275) | 187 (282) | 172 (272) | 184 (269)b | 178 (271) | 175 (297)a | 190 (269) | 178 (280) |
creatinine (mg/dl) | 9.2 (3.2) | 8.0 (3.1)a | 9.2 (3.0) | 9.2 (3.5)a | 8.9 (3.1) | 10.1 (3.2)a | 7.3 (3.0) | 9.2 (3.2)a |
ferritin (ng/ml) | 285 (431) | 247 (403)c | 314 (456) | 203 (332)a | 286 (429) | 222 (439)b | 278 (410) | 273 (426)a |
Serum parathyroid hormone and ferritin values are summarized as median (interquartile range). Significance values obtained from logistic and mixed linear regression models adjusted for the Dialysis Outcomes and Practice Patterns Study phase and accounted for facility clustering effects. KD, dialysate potassium.
P<0.001 for “yes” versus “no” column.
0.05≤P<0.10 for “yes” versus “no” column.
0.001≤P<0.05 for “yes” versus “no” column.